|
 |
In association with 
|
|
| Breaking News on Pharmaceutical Technology |
||
|
||
| Daily
Monday 17 December 2007 |
 Forward to a colleague |
|
|
Access Full Stories  Patheon reveals plans to tackle Puerto Rico problemsPatheon has finally revealed its plans to tackle the ongoing problems it has been facing with its Puerto Rican operations, which are draining the firm of profitability... Read Japan says Tamiflu/psychiatric link unclear Any link between the antiviral Tamiflu and neuropsychiatric problems is inconclusive, according to the Japanese Government... Read Pronova and FMC to develop seaweed-derived capsules Pronova BioPharma and FMC Corporation have signed a license and development agreement to develop products using an alginate-based capsule technology... Read Double whammy as Merck kids' vaccines recalled and suspended Merck has been hit with a contamination threat prompting the recall of a million of its childhood Hib vaccines across the US, right alongside the Canadian suspension of its MMR vaccine... Read China's API manufacturers facing further crackdowns The first steps in tightening the safety controls on the pharmaceutical ingredients imported to the US from China have been taken following months of negotiations between the regulatory bodies of the two countries... Read |
|
||||||||||||||||
All News Headlines for: December | November | October |
||||||||||||||||||
 Product PresentationFirst ever syringe leak testing machine Bonfiglioli's new leak tester will be the first one ever on the market. Customised to client requirements, each individual syringe will be 100% tested and faulty syringes will be automatically removed from the nest by a pick and place system. The output may reach up to... Click Here | ||||||||||||||||||
|
||||||||||||||||||
|
Related Industry News Semen fibrils ferry HIV into cells Tiny protein fibres in semen have been found to enhance the ability of HIV to infect cells by up to 100,000 fold and could provide drug developers with a potent new target to tackle the virus... Read Shire snaps up Alba's gastrointestinal drug for $325m US biopharma firm Alba Therapeutics has received a boost to its coffers after Shire agreed to pay up to $325m (€226m) to help bring its lead gastrointestinal drug candidate to market... Read Curiox' mini-bioassay tech to aid cheaper drug development Curiox Biosystems has developed a miniaturisation platform that enables cheaper and more efficient bioassays to be conducted, potentially slashing the costs of life science and drug discovery research... Read Biogen Idec shares nosedive after withdrawing 'for sale' sign Like countless pets after every Christmas, it seems that nobody wanted Biogen Idec after all; the firm has announced it will remain independent after it 'did not receive any definitive offers to purchase the company'... Read
|
||||||||||||||||||
|
|
|
|||
| Forward to a colleague |
|||||
|
To continue to receive this newsletter in your inbox, please add newsletter@In-PharmaTechnologist.com to your address book |
|
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||
